CANNES, France, Sept. 13 - Ask bioethicist Arthur Caplan what's at the top of his wish list and he'll tell you: an in-house bioethicist in every genomic, bioinformatic, and microarray company worldwide within the next 10 years.
NEW YORK, Sept 11 – Microarray developer NimbleGen Systems of Madison, Wis., said Tuesday it had raised $9 million in a private round of financing. The company has raised more than $12.5 million in total.
NEW YORK, Sept 11 – AlphaGene of Woburn, Mass., said Tuesday it has signed an agreement with Wayne State University to study malignant brain tumor cell types using gene expression technology. Under the terms of the deal, AlphaGene will
NESS ZIONA, Israel, Sept 11 – Genomic research often amounts to looking for a needle in a haystack as researchers plow through vast amounts of data searching for clues that will implicate a gene’s or a protein’s role in disease. But at Quark Biotec
NEW YORK, Sept 10 – Incyte Genomics said Monday it had extended a deal with Galapagos Genomics of Mechelen, Belgium to further develop an adenoviral library for Incyte’s in-house drug development program. Under the terms of the agreemen
NEW YORK, Sept. 10 - Genops Bioinformatics signed an exclusive sales and marketing arrangement with Samsung Corp. for the Asia/Oceania market, the company announced Monday. Under the partnership, Samsung Corp.
NEW YORK, Sept 10 – Atugen, a Berlin-based functional genomics company, said Monday that Arena Pharmaceuticals had agreed to evaluate its G-protein coupled receptor technology. Under the terms of the deal, Atugen’s US-based subsidiary w
NEW YORK, Sept 10 – Affymetrix said Monday that it had expanded its agreement to provide GlaxoSmithKline with its GeneChip technology. Under the terms of the deal, Glaxo’s research centers will be able to receive customized GeneCh
NEW YORK, Sept. 7 – Proteomics and microarray developer Genomic Solutions said on Friday it plans to cut 25 percent of its workforce and restructure its business to help it become profitable by the first quarter of next year.
Like genomics, the field of proteomics reverses traditional methodologies of protein characterization. It comes as no surprise, then, that proteomics can expect problems similar to those faced when attempting to patent genomics inventions.
NEW YORK, Sept. 7 – Genops Bioinformatics and bioinformatics startup Zerosum plan to enter an information-sharing partnership to help Genops broaden its Ngene software and boost Zerosum’s burgeoning business, the companies said this week.
SAN FRANCISCO, Sept. 6 - Structural Genomix has committed to buy $2 million to $3 million worth of equipment from Compaq and to explore a longer-term strategic relationship with the firm, both companies told GenomeWeb .